AbbVie trims full-year profit forecast on higher R&D expenses
(Reuters) -AbbVie Inc cut its full-year profit forecast on Thursday, citing $280 million in milestone and in-process research and development expenses during the second quarter. The company now expects adjusted profit between $10.57 and $10.97 per share, compared with $10.72 to $11.12 it previously expected. Analysts on average were expecting full-year earnings of $10.97 per …
AbbVie trims full-year profit forecast on higher R&D expenses Read More »










